Citigroup’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,000
| Closed | -$1K | – | 5708 |
|
|
2020
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 5172 |
|
|
2020
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 5013 |
|
|
2020
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 5011 |
|
|
2020
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 5040 |
|
|
2019
Q4 | $2K | Sell |
1,000
-60,438
| -98% | -$121K | ﹤0.01% | 5017 |
|
|
2019
Q3 | $91K | Sell |
61,438
-1,796
| -3% | -$2.66K | ﹤0.01% | 3497 |
|
|
2019
Q2 | $82K | Buy |
63,234
+1,738
| +3% | +$2.25K | ﹤0.01% | 3761 |
|
|
2019
Q1 | $161K | Buy |
61,496
+1,058
| +2% | +$2.77K | ﹤0.01% | 3268 |
|
|
2018
Q4 | $100K | Sell |
60,438
-2,133
| -3% | -$3.53K | ﹤0.01% | 3497 |
|
|
2018
Q3 | $304K | Buy |
62,571
+15,474
| +33% | +$75.2K | ﹤0.01% | 2873 |
|
|
2018
Q2 | $294K | Buy |
47,097
+43,866
| +1,358% | +$274K | ﹤0.01% | 2683 |
|
|
2018
Q1 | $26K | Buy |
3,231
+3,019
| +1,424% | +$24.3K | ﹤0.01% | 4108 |
|
|
2017
Q4 | $2K | Buy |
212
+138
| +186% | +$1.3K | ﹤0.01% | 4841 |
|
|
2017
Q3 | $1K | Sell |
74
-464
| -86% | -$6.27K | ﹤0.01% | 4654 |
|
|
2017
Q2 | $4K | Sell |
538
-109
| -17% | -$810 | ﹤0.01% | 4404 |
|
|
2017
Q1 | $5K | Buy |
647
+38
| +6% | +$294 | ﹤0.01% | 4488 |
|
|
2016
Q4 | $4K | Sell |
609
-3,720
| -86% | -$24.4K | ﹤0.01% | 4707 |
|
|
2016
Q3 | $28K | Sell |
4,329
-277
| -6% | -$1.79K | ﹤0.01% | 4028 |
|
|
2016
Q2 | $43K | Sell |
4,606
-813
| -15% | -$7.59K | ﹤0.01% | 3776 |
|
|
2016
Q1 | $58K | Buy |
5,419
+73
| +1% | +$781 | ﹤0.01% | 4222 |
|
|
2015
Q4 | $77K | Buy |
5,346
+5,195
| +3,440% | +$74.8K | ﹤0.01% | 3775 |
|
|
2015
Q3 | $3K | Buy |
+151
| New | +$3K | ﹤0.01% | 4844 |
|